Triangle Securities Wealth Management »

Biogen Idec shares owned by Triangle Securities Wealth Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Triangle Securities Wealth Management from 13F filings

Historical chart of Triangle Securities Wealth Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Triangle Securities Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Triangle Securities Wealth Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $1.9M 9.9k 192.64
2012-12-31 $1.5M 10k 146.34
2012-09-30 $1.5M 10k 149.17
2012-06-30 $1.5M 10k 144.36
2012-03-31 $1.3M 10k 125.96
2011-12-31 $1.1M 10k 110.09

More positions owned by Triangle Securities Wealth Management

Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Vanguard World Inf Tech Etf (VGT)
Microsoft Corporation (MSFT)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Total Usd (IUSB)
Managed Portfolio Series Tortoise Nram Pi (TPYP)
Advisors Inner Circle Fd Iii Strategas Macro (SAMT)
Kkr & Co (KKR)
Apple (AAPL)
Blackstone Group Inc Com Cl A (BX)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)

View all positions for Triangle Securities Wealth Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec